Similarly, Gnas gain-of-function mutation (R201C [43] or R201H [44]) induces low-grade IPMN that, when combined with oncogenic Kras, results in accelerated progression to invasive PDAC. The gene discussed is KRAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.